Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Ovary > FOV8011a
  • Cores:
    80
    CASES:
    80
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
FOV8011a
$215.00
Add To Collect

Description: Ovarian epithelial cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores

Details: Ovarian carcinoma tissue microarray with adjacent normal tissue, containing 42 cases of serous adenocarcinoma, 8 cases of clear cell carcinoma, 15 cases of endometrioid adenocarcinoma, 10 cases of mucinous adenocarcinoma, 5 cases of adjacent normal tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(IIB)
  • Malignant(IIIA)
  • Malignant(IIIC)
  • Malignant(III)
  • _ma
TISSUE ARRAYS
FOV8011a
1
2
3
4
5
6
7
8
9
10
A
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
B
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
C
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
D
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
E
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
F
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
G
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
H
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
Ova
_ma
FOV8011a
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size CK7 P53
A1
1 58 F Ovary Serous adenocarcinoma 1 T3cN0M0 IIIC Malignant - ++,100% -
A2
2 29 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant - ++,100% ++,75%
A3
3 40 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - +++,100% +,5%
A4
4 41 F Ovary Serous adenocarcinoma 1 T1N0M0 I Malignant 6*4*2.5 ++,100% +,5%
A5
5 23 F Ovary Serous adenocarcinoma 1 T2bN0M0 IIB Malignant 2.8*2*1.5 +++,100% -
A6
6 45 F Ovary Serous adenocarcinoma 1 T1aN0M0 IA Malignant - ++,100% -
A7
7 35 F Ovary Serous papillary adenocarcinoma 1 T1cN0M0 IC Malignant 15*10*4 ++,90% -
A8
8 75 F Ovary Serous papillary adenocarcinoma 2 T1aN0M0 IA Malignant - ++,100% ++,45%
A9
9 49 F Ovary Serous adenocarcinoma 2 T1N0M0 I Malignant 8*4.5*4 ++,90% -
A10
10 53 F Ovary Serous adenocarcinoma (sparse) 2 T3N0M0 III Malignant 4*3*1.5 +,80% ++,75%
B1
11 39 F Ovary Serous adenocarcinoma with necrosis 2--3 T3cN0M0 IIIC Malignant 6*4*4 ++,80% -
B2
12 49 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5.5*5 ++,80% +++,90%
B3
13 79 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 14*8*6 ++,90% -
B4
14 56 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 6*5*3 +,80% -
B5
15 57 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5*4 ++,100% ++,85%
B6
16 58 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 9*5.5*2 ++,80% ++,85%
B7
17 51 F Ovary Serous adenocarcinoma 3 T1bN0M0 IB Malignant 8*6*2 ++,100% +,10%
B8
18 75 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1N0M0 I Malignant 5*4*3 +++,100% +,40%
B9
19 51 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 7*6*4 +,30% +,10%
B10
20 43 F Ovary Serous adenocarcinoma 3 T3N0M0 III Malignant - ++,90% +,40%
C1
21 53 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N1M0 IIIC Malignant 3*2*1 ++,90% +,30%
C2
22 55 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant 4.5*3.0*3.0 ++,100% ++,65%
C3
23 41 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N0M0 III Malignant - ++,80% ++,75%
C4
24 55 F Ovary Serous adenocarcinoma 3 T1cN0M0 IC Malignant 9 ++,60% +,30%
C5
25 67 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1aN0M0 IA Malignant 9*6*5.5 +,60% +,25%
C6
26 48 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3aN0M0 IIIA Malignant 7*4*2.5 ++,70% ++,65%
C7
27 67 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 13*12*6 +,40% ++,80%
C8
28 43 F Ovary Serous adenocarcinoma (interstitial) * T3cN0M0 IIIC Malignant 8*7*4 ++,100% +,30%
C9
29 37 F Ovary Serous adenocarcinoma 2 T1aN0M0 IA Malignant 6.5*4.5*3.0 +++,100% ++,80%
C10
30 49 F Ovary Serous adenocarcinoma 3 T3N1M0 IIIC Malignant 9 +++,100% +,80%
D1
31 58 F Ovary Serous adenocarcinoma 3 T3cN0M0 IIIC Malignant - ++,90% +,70%
D2
32 43 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - ++,40% +,5%
D3
33 56 F Ovary Serous adenocarcinoma 3 T1aN0M0 IA Malignant - +++,100% -
D4
34 52 F Ovary Serous adenocarcinoma 2 T3N0M0 III Malignant - ++,40% ++,40%
D5
35 50 F Ovary Serous adenocarcinoma 3 T1aN1M0 IIIC Malignant - ++,100% +,15%
D6
36 40 F Ovary Serous adenocarcinoma (sparse) 3 T1aN0M0 IA Malignant - ++,80% +,40%
D7
37 47 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1aN1M0 IIIC Malignant 7 ++,100% +,15%
D8
38 46 F Ovary Serous adenocarcinoma 3 T2bN1M0 IIIC Malignant 6 ++,100% -
D9
39 27 F Ovary Serous adenocarcinoma 1--2 T3cN0M0 IIIC Malignant - +++,100% +,5%
D10
40 38 F Ovary Serous adenocarcinoma 3 T1N0M0 I Malignant 11*8*4 ++,90% +,60%
E1
41 43 F Ovary Serous adenocarcinoma with sparse necrosis 3 T3N1M0 IIIC Malignant 13*10*5 ++,90% +,65%
E2
42 53 F Ovary Serous adenocarcinoma with sparse necrosis 3 T1N0M0 I Malignant 9**6*5 +,40% ++,80%
E3
43 61 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 12*6*6 +,90% +,5%
E4
44 42 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 9.5*5*1 +,40% -
E5
45 53 F Ovary Clear cell carcinoma 2 T1bN0M0 IB Malignant 10*7*2 +,90% -
E6
46 58 F Ovary Clear cell carcinoma 2 T1N0M0 I Malignant 10*10*7 +,40% -
E7
47 43 F Ovary Clear cell carcinoma 1 T1aN0M0 IA Malignant 7*4*3 ++,80% -
E8
48 40 F Ovary Clear cell carcinoma 2 T3cN0M0 IIIC Malignant - +,40% -
E9
49 54 F Ovary Clear cell carcinoma 2 T2N0M0 IIB Malignant 5 ++,80% -
E10
50 58 F Ovary Clear cell carcinoma 2 T1aN0M0 IA Malignant 11.2*9.7*4.3 ++,80% -
F1
51 55 F Ovary Endometrioid adenocarcinoma 1--2 T1aN0M0 IA Malignant 11*9*7 ++,100% -
F2
52 44 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant - +++,100% -
F3
53 60 F Ovary Endometrioid adenocarcinoma 2 T3N0M0 III Malignant - ++,100% -
F4
54 49 F Ovary Endometrioid adenocarcinoma with necrosis 2 T1aN0M0 IA Malignant 12*11*5 - ++,80%
F5
55 33 F Ovary Endometrioid adenocarcinoma 2 T1N0M0 I Malignant 7*5*4 ++,80% -
F6
56 54 F Ovary Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4.5*2.5*2 +++,100% -
F7
57 54 F Ovary Endometrioid adenocarcinoma 2 T1cN0M0 IC Malignant 18*13*8 ++,90% -
F8
58 55 F Ovary Endometrioid adenocarcinoma 2--3 T1cN0M0 IC Malignant 13*10*5.5 ++,100% -
F9
59 47 F Ovary Endometrioid adenocarcinoma 3 T1N0M0 I Malignant - +,40% ++,80%
F10
60 48 F Ovary Endometrioid adenocarcinoma 2--3 T3cN0M0 IIIC Malignant - +,30% +,30%
G1
61 58 F Ovary Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant - +,30% +,30%
G2
62 30 F Ovary Endometrioid adenocarcinoma 2--3 T1N0M0 I Malignant 16*9*7 ++,100% -
G3
63 46 F Ovary Endometrioid adenocarcinoma 3 T1N0M0 I Malignant 9*5*3 +++,100% -
G4
64 45 F Ovary Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant - ++,80% -
G5
65 55 F Ovary Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant - +,70% -
G6
66 43 F Ovary Mucinous adenocarcinoma 1 T3cN0M0 IIIC Malignant 6*4*2.5 - -
G7
67 54 F Ovary Mucinous adenocarcinoma 1--2 T1bN0M0 IB Malignant - ++,70% -
G8
68 48 F Ovary Mucinous adenocarcinoma 2 T1aN0M0 IA Malignant - - -
G9
69 24 F Ovary Mucinous adenocarcinoma with sparae necrosis 2 T3N0M0 III Malignant - ++,80% -
G10
70 49 F Ovary Mucinous adenocarcinoma 2 T1N0M0 I Malignant 8.5*6*2 +,80% +,35%
H1
71 50 F Ovary Mucinous adenocarcinoma 3 T3cN1M0 IIIC Malignant 7*5*3 ++,100% +,45%
H2
72 40 F Ovary Mucinous adenocarcinoma 3 T1aN0M0 IA Malignant 7*4*3 +,60% +,10%
H3
73 45 F Ovary Mucinous adenocarcinoma 3 T1aN0M0 IA Malignant - +++,100% +,5%
H4
74 50 F Ovary Mucinous adenocarcinoma 3 T2N0M0 IIB Malignant 7*4*4 ++,100% -
H5
75 40 F Ovary Mucinous adenocarcinoma 3 T1cN0M0 IC Malignant - +,70% +,5%
H6
76 52 F Ovary Adjacent normal ovary tissue * * * NAT - - -
H7
77 71 F Ovary Adjacent normal ovary tissue * * * NAT - - -
H8
78 41 F Ovary Adjacent normal ovary tissue * * * NAT - ++,100%,上皮 -
H9
79 48 F Ovary Adjacent normal ovary tissue * * * NAT - - -
H10
80 36 F Ovary Adjacent normal ovary tissue * * * NAT - - -
_marker_
Find overlapping cases with this tissue array:
  • FOV8011a
    File Format: .xls
    Release Date: 2025-01-17 16:00:35
    Download
0.401119s